Similar Items: Epidermal Growth Factor Receptor Kinase Domain Duplication in Lung Adenocarcinoma with Sensitive Response to Afatinib: A Case Report and Literature Review
- The epidermal growth factor receptor (EGRF) in lung cancer
- Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China
- Drug‐Induced Lung Injury Masking Lung Adenocarcinoma
- DLGAP5 Drives Lung Adenocarcinoma Cell Growth by Promoting Autophagy Activity
- Atypical Spread With Lung Shrinkage and Cystic Changes in Bilateral Lepidic Adenocarcinoma
- Successful Introduction of Lorlatinib After Drug Eruption With Alectinib in ALK‐Positive Lung Adenocarcinoma: A Case Report